Considering participation in a clinical trial is often a very difficult decision for patients, especially those dealing with a rare disease.
Considering participation in a clinical trial is often a very difficult decision for patients, especially those dealing with a rare disease. In this video, leading CTCL experts address the question of when a patient should consider entering a clinical trial.
The video features expert insights from:
This video is one of several featured in the CLF’s Online Learning Center. Other topics include recommendations for managing itch and a three-part overview of treatments for cutaneous lymphoma.
For more information, visit http://www.clfoundation.org/online-learning-center.
Shared Model of Care Post-HCT Offers Safe Follow-Up, Reduces Patient Burden
Published: March 19th 2025 | Updated: March 19th 2025Alternating post-HCT care between specialized facilities and local cancer centers produced noninferior non-relapse mortality and similar quality of life to usual care.